-
1
-
-
20444409135
-
Latest advances in understanding preeclampsia
-
DOI 10.1126/science.1111726
-
Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308: 1592-4. (Pubitemid 40807500)
-
(2005)
Science
, vol.308
, Issue.5728
, pp. 1592-1594
-
-
Redman, C.W.1
Sargent, I.L.2
-
3
-
-
0034619029
-
Pre-eclampsia
-
Walker JJ. Pre-eclampsia. Lancet 2000;356: 1260-5.
-
(2000)
Lancet
, vol.356
, pp. 1260-5
-
-
Walker, J.J.1
-
6
-
-
0035938977
-
Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129 290 births
-
DOI 10.1016/S0140-6736(00)05112-6
-
Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 births. Lancet 2001;357:2002-6. (Pubitemid 32592386)
-
(2001)
Lancet
, vol.357
, Issue.9273
, pp. 2002-2006
-
-
Smith, G.C.S.1
Pell, J.P.2
Walsh, D.3
-
7
-
-
35548980979
-
Hypertension in pregnancy: An emerging risk factor for cardiovascular disease
-
DOI 10.1038/ncpneph0623, PII NCPNEPH0623
-
Garovic VD, Hayman SR. Hypertension in pregnancy: An emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007;3: 613-22. (Pubitemid 350012820)
-
(2007)
Nature Clinical Practice Nephrology
, vol.3
, Issue.11
, pp. 613-622
-
-
Garovic, V.D.1
Hayman, S.R.2
-
8
-
-
79959507759
-
Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease
-
Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123: 2856-69.
-
Circulation
, vol.123
, pp. 2856-69
-
-
Powe, C.E.1
Levine, R.J.2
Karumanchi, S.A.3
-
9
-
-
0024398644
-
Preeclampsia: An endothelial cell disorder
-
Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-4. (Pubitemid 20007682)
-
(1989)
American Journal of Obstetrics and Gynecology
, vol.161
, Issue.5
, pp. 1200-1204
-
-
Roberts, J.M.1
Taylor, R.N.2
Musci, T.J.3
Rodgers, G.M.4
Hubel, C.A.5
McLaughlin, M.K.6
-
11
-
-
0037370325
-
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
-
DOI 10.1172/JCI200317423
-
Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003;111: 707-16. (Pubitemid 36278589)
-
(2003)
Journal of Clinical Investigation
, vol.111
, Issue.5
, pp. 707-716
-
-
Eremina, V.1
Sood, M.2
Haigh, J.3
Nagy, A.4
Lajoie, G.5
Ferrara, N.6
Gerber, H.-P.7
Kikkawa, Y.8
Miner, J.H.9
Quaggin, S.E.10
-
12
-
-
40849130173
-
VEGF inhibition and renal thrombotic microangiopathy
-
DOI 10.1056/NEJMoa0707330
-
Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358:1129-36. (Pubitemid 351398487)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.11
, pp. 1129-1136
-
-
Eremina, V.1
Jefferson, J.A.2
Kowalewska, J.3
Hochster, H.4
Haas, M.5
Weisstuch, J.6
Richardson, C.7
Kopp, J.B.8
Kabir, M.G.9
Backx, P.H.10
Gerber, H.-P.11
Ferrara, N.12
Barisoni, L.13
Alpers, C.E.14
Quaggin, S.E.15
-
13
-
-
39649122843
-
A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib
-
DOI 10.1093/jnci/djm311
-
Patel TV, Morgan JA, Demetri GD, George S, Maki RG, Quigley M, Humphreys BD. A preeclampsialike syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib. J Natl Cancer Inst 2008;100:282-4. (Pubitemid 351480534)
-
(2008)
Journal of the National Cancer Institute
, vol.100
, Issue.4
, pp. 282-284
-
-
Patel, T.V.1
Morgan, J.A.2
Demetri, G.D.3
George, S.4
Maki, R.G.5
Quigley, M.6
Humphreys, B.D.7
-
14
-
-
0037373006
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia
-
DOI 10.1172/JCI200317189
-
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58. (Pubitemid 36278583)
-
(2003)
Journal of Clinical Investigation
, vol.111
, Issue.5
, pp. 649-658
-
-
Maynard, S.E.1
Min, J.-Y.2
Merchan, J.3
Lim, K.-H.4
Li, J.5
Mondal, S.6
Libermann, T.A.7
Morgan, J.P.8
Sellke, F.W.9
Stillman, I.E.10
Epstein, F.H.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
15
-
-
0038030642
-
Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia
-
DOI 10.1210/jc.2002-021942
-
Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003;88:2348-51. (Pubitemid 36549917)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.5
, pp. 2348-2351
-
-
Koga, K.1
Osuga, Y.2
Yoshino, O.3
Hirota, Y.4
Ruimeng, X.5
Hirata, T.6
Takeda, S.7
Yano, T.8
Tsutsumi, O.9
Taketani, Y.10
-
16
-
-
10744232684
-
Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences
-
DOI 10.1210/jc.2003-030528
-
Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences. J Clin Endocrinol Metab 2003;88: 5555-63. (Pubitemid 37452769)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.11
, pp. 5555-5563
-
-
Tsatsaris, V.1
Goffin, F.2
Munaut, C.3
Brichant, J.-F.4
Pignon, M.-R.5
Noel, A.6
Schaaps, J.-P.7
Cabrol, D.8
Frankenne, F.9
Foidart, J.-M.10
-
17
-
-
7244238090
-
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
-
DOI 10.1161/01.RES.0000147365.86159.f5
-
Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004;95:884-91. (Pubitemid 39435003)
-
(2004)
Circulation Research
, vol.95
, Issue.9
, pp. 884-891
-
-
Ahmad, S.1
Ahmed, A.2
-
19
-
-
0031771617
-
A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation
-
Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998;59:1540-8. (Pubitemid 28549874)
-
(1998)
Biology of Reproduction
, vol.59
, Issue.6
, pp. 1540-1548
-
-
Clark, D.E.1
Smith, S.K.2
He, Y.3
Day, K.A.4
Licence, D.R.5
Corps, A.N.6
Lammoglia, R.7
Charnock-Jones, D.S.8
-
20
-
-
18044370643
-
Circulating angiogenic factors in preeclampsia
-
DOI 10.1097/01.grf.0000160313.82606.d7
-
Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 2005;48:372-86. (Pubitemid 40605141)
-
(2005)
Clinical Obstetrics and Gynecology
, vol.48
, Issue.2
, pp. 372-386
-
-
Levine, R.J.1
Karumanchi, S.A.2
-
21
-
-
77955145573
-
Reduction of circulating soluble Flt-1 alleviates preeclampsialike symptoms in a mouse model
-
Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, Lindenmaier W, et al. Reduction of circulating soluble Flt-1 alleviates preeclampsialike symptoms in a mouse model. J Cell Mol Med 2010;14:1857-67.
-
(2010)
J Cell Mol Med
, vol.4
, pp. 1857-1867
-
-
Bergmann, A.1
Ahmad, S.2
Cudmore, M.3
Gruber, A.D.4
Wittschen, P.5
Lindenmaier, W.6
-
22
-
-
36448996940
-
Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression
-
DOI 10.1161/HYPERTENSIONAHA.107.096594
-
Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007;50:1142-7. (Pubitemid 350172938)
-
(2007)
Hypertension
, vol.50
, Issue.6
, pp. 1142-1147
-
-
Gilbert, J.S.1
Babcock, S.A.2
Granger, J.P.3
-
23
-
-
79952145885
-
Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model
-
Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A 2011;108:1451-5.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 1451-5
-
-
Kumasawa, K.1
Ikawa, M.2
Kidoya, H.3
Hasuwa, H.4
Saito-Fujita, T.5
Morioka, Y.6
-
24
-
-
33947619480
-
The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice
-
e1-7
-
Lu F, Longo M, Tamayo E, Maner W, Al-Hendy A, Anderson GD, et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol 2007;196:396 e1-7.
-
(2007)
Am J Obstet Gynecol
, vol.196
, pp. 396
-
-
Lu, F.1
Longo, M.2
Tamayo, E.3
Maner, W.4
Al-Hendy, A.5
Anderson, G.D.6
-
25
-
-
34248341332
-
Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1
-
DOI 10.1038/sj.ki.5002175, PII 5002175
-
Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFlt-1. Kidney Int 2007;71:977-84. (Pubitemid 46741987)
-
(2007)
Kidney International
, vol.71
, Issue.10
, pp. 977-984
-
-
Makris, A.1
Thornton, C.2
Thompson, J.3
Thomson, S.4
Martin, R.5
Ogle, R.6
Waugh, R.7
McKenzie, P.8
Kirwan, P.9
Hennessy, A.10
-
26
-
-
20244362656
-
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
-
DOI 10.1080/14767050400028816
-
Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005;17:3-18. (Pubitemid 40515938)
-
(2005)
Journal of Maternal-Fetal and Neonatal Medicine
, vol.17
, Issue.1
, pp. 3-18
-
-
Chaiworapongsa, T.1
Romero, R.2
Kim, Y.M.3
Kim, G.J.4
Kim, M.R.5
Espinoza, J.6
Bujold, E.7
Goncalves, L.8
Gomez, R.9
Edwin, S.10
Mazor, M.11
-
27
-
-
4344564076
-
Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia [1]
-
DOI 10.1373/clinchem.2004.036715
-
Hertig A, Berkane N, Lefevre G, Toumi K, Marti HP, Capeau J, et al. Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004;50: 1702-3. (Pubitemid 39121252)
-
(2004)
Clinical Chemistry
, vol.50
, Issue.9
, pp. 1702-1703
-
-
Hertig, A.1
Berkane, N.2
Lefevre, G.3
Toumi, K.4
Marti, H.-P.5
Capeau, J.6
Uzan, S.7
Rondeau, E.8
-
28
-
-
10744227199
-
Circulating angiogenic factors and the risk of preeclampsia
-
DOI 10.1056/NEJMoa031884
-
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83. (Pubitemid 38364626)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.7
, pp. 672-683
-
-
Levine, R.J.1
Maynard, S.E.2
Qian, C.3
Lim, K.-H.4
England, L.J.5
Yu, K.F.6
Schisterman, E.F.7
Thadhani, R.8
Sachs, B.P.9
Epstein, F.H.10
Sibai, B.M.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
29
-
-
33744985816
-
Soluble endoglin contributes to the pathogenesis of preeclampsia
-
DOI 10.1038/nm1429, PII N1429
-
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-9. (Pubitemid 43865232)
-
(2006)
Nature Medicine
, vol.12
, Issue.6
, pp. 642-649
-
-
Venkatesha, S.1
Toporsian, M.2
Lam, C.3
Hanai, J.-I.4
Mammoto, T.5
Kim, Y.M.6
Bdolah, Y.7
Lim, K.-H.8
Yuan, H.-T.9
Libermann, T.A.10
Stillman, I.E.11
Roberts, D.12
D'Amore, P.A.13
Epstein, F.H.14
Sellke, F.W.15
Romero, R.16
Sukhatme, V.P.17
Letarte, M.18
Karumanchi, S.A.19
-
30
-
-
33748421660
-
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
-
DOI 10.1056/NEJMoa055352
-
Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005. (Pubitemid 44343543)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.10
, pp. 992-1005
-
-
Levine, R.J.1
Lam, C.2
Qian, C.3
Yu, K.F.4
Maynard, S.E.5
Sachs, B.P.6
Sibai, B.M.7
Epstein, F.H.8
Romero, R.9
Thadhani, R.10
Karumanchi, S.A.11
-
31
-
-
79551488222
-
Circulating angiogenic and antiangiogenic factors in women with eclampsia
-
Vaisbuch E, Whitty JE, Hassan SS, Romero R, Kusanovic JP, Cotton DB, et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol 2011;204:152 e1-9.
-
(2011)
Am J Obstet Gynecol
, vol.204
-
-
Vaisbuch, E.1
Whitty, J.E.2
Hassan, S.S.3
Romero, R.4
Kusanovic, J.P.5
Cotton, D.B.6
-
32
-
-
79251528214
-
New insights into the etiology of preeclampsia: Identification of key elusive factors for the vascular complications
-
Ahmed A. New insights into the etiology of preeclampsia: Identification of key elusive factors for the vascular complications. Thromb Res 2011; 127(Suppl 3):S72-5.
-
(2011)
Thromb Res
, vol.127
, Issue.SUPPL. 3
-
-
Ahmed, A.1
-
33
-
-
1442303327
-
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia
-
DOI 10.1210/jc.2003-031244
-
Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770-5. (Pubitemid 38269892)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.2
, pp. 770-775
-
-
Thadhani, R.1
Mutter, W.P.2
Wolf, M.3
Levine, R.J.4
Taylor, R.N.5
Sukhatme, V.P.6
Ecker, J.7
Karumanchi, S.A.8
-
34
-
-
24644473695
-
Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia
-
DOI 10.1016/j.ejogrb.2004.11.015, PII S0301211504006049
-
Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005;122:33-9. (Pubitemid 41265677)
-
(2005)
European Journal of Obstetrics Gynecology and Reproductive Biology
, vol.122
, Issue.1
, pp. 33-39
-
-
Staff, A.C.1
Braekke, K.2
Harsem, N.K.3
Lyberg, T.4
Holthe, M.R.5
-
35
-
-
77955417702
-
Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension
-
Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 122:478-87.
-
Circulation
, vol.122
, pp. 478-87
-
-
Noori, M.1
Donald, A.E.2
Angelakopoulou, A.3
Hingorani, A.D.4
Williams, D.J.5
-
36
-
-
37849021866
-
A longitudinal study of angiogenic (placental growth factor) and anti-Angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
-
Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-Angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21: 9-23.
-
(2008)
J Matern Fetal Neonatal Med
, vol.21
, pp. 9-23
-
-
Romero, R.1
Nien, J.K.2
Espinoza, J.3
Todem, D.4
Fu, W.5
Chung, H.6
-
37
-
-
0037245823
-
Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies
-
DOI 10.1067/mob.2003.111
-
Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188: 177-82. (Pubitemid 36135616)
-
(2003)
American Journal of Obstetrics and Gynecology
, vol.188
, Issue.1
, pp. 177-182
-
-
Taylor, R.N.1
Grimwood, J.2
Taylor, R.S.3
McMaster, M.T.4
Fisher, S.J.5
North, R.A.6
-
38
-
-
19944426139
-
Urinary placental growth factor and risk f preeclampsia
-
DOI 10.1001/jama.293.1.77
-
Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005;293:77-85. (Pubitemid 40066702)
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.1
, pp. 77-85
-
-
Levine, R.J.1
Thadhani, R.2
Qian, C.3
Lam, C.4
Lim, K.-H.5
Yu, K.F.6
Blink, A.L.7
Sachs, B.P.8
Epstein, F.H.9
Sibai, B.M.10
Sukhatme, V.P.11
Karumanchi, S.A.12
-
39
-
-
20344396618
-
Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry
-
DOI 10.1016/j.ijgo.2005.02.008, PII S0020729205001621
-
Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V. Prediction of preeclampsia with maternal midtrimester placental growth factor, activin a, fibronectin and uterine artery doppler velocimetry. Int J Gynaecol Obstet 2005;89:251-7. (Pubitemid 40779295)
-
(2005)
International Journal of Gynecology and Obstetrics
, vol.89
, Issue.3
, pp. 251-257
-
-
Madazli, R.1
Kuseyrioglu, B.2
Uzun, H.3
Uludag, S.4
Ocak, V.5
-
40
-
-
49649115769
-
Endoglin PlGF and sFlt-1 as markers for predicting pre-eclampsia
-
De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'Anna R. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand 2008;87:837-42.
-
(2008)
Acta Obstet Gynecol Scand
, vol.87
, pp. 837-42
-
-
De Vivo, A.1
Baviera, G.2
Giordano, D.3
Todarello, G.4
Corrado, F.5
D'Anna, R.6
-
41
-
-
47749139356
-
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors
-
Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008;111:1403-9.
-
(2008)
Obstet Gynecol
, vol.111
, pp. 1403-9
-
-
Lim, J.H.1
Kim, S.Y.2
Park, S.Y.3
Yang, J.H.4
Kim, M.Y.5
Ryu, H.M.6
-
42
-
-
75049083263
-
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
-
202
-
Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161 e1-e11.
-
(2010)
Am J Obstet Gynecol
, vol.161
-
-
Verlohren, S.1
Galindo, A.2
Schlembach, D.3
Zeisler, H.4
Herraiz, I.5
Moertl, M.G.6
-
43
-
-
50349085834
-
First-Trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-Trimester markers for late-onset preeclampsia
-
Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV. First-Trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-Trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008;199:266 e1-6.
-
(2008)
Am J Obstet Gynecol
, vol.199
-
-
Baumann, M.U.1
Bersinger, N.A.2
Mohaupt, M.G.3
Raio, L.4
Gerber, S.5
Surbek, D.V.6
-
44
-
-
34249874048
-
Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth
-
DOI 10.1097/01.AOG.0000265804.09161.0d, PII 0000625020070600000010
-
Smith GC, Crossley JA, Aitken DA, Jenkins N, Lyall F, Cameron AD, et al. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth. Obstet Gynecol 2007;109:1316-24. (Pubitemid 46869870)
-
(2007)
Obstetrics and Gynecology
, vol.109
, Issue.6
, pp. 1316-1324
-
-
Smith, G.C.S.1
Crossley, J.A.2
Aitken, D.A.3
Jenkins, N.4
Lyall, F.5
Cameron, A.D.6
Connor, J.M.7
Dobbie, R.8
-
45
-
-
34250858133
-
Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia
-
DOI 10.1161/HYPERTENSIONAHA.107.087700, PII 0000426820070700000024
-
Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007;50:137-42. (Pubitemid 46986022)
-
(2007)
Hypertension
, vol.50
, Issue.1
, pp. 137-142
-
-
Rana, S.1
Karumanchi, S.A.2
Levine, R.J.3
Venkatesha, S.4
Rauh-Hain, J.A.5
Tamez, H.6
Thadhani, R.7
-
46
-
-
56249113278
-
Screening for placental insufficiency in high-risk pregnancies: Is earlier better?
-
Costa SL, Proctor L, Dodd JM, Toal M, Okun N, Johnson JA, et al. Screening for placental insufficiency in high-risk pregnancies: Is earlier better? Placenta 2008;29:1034-40.
-
(2008)
Placenta
, vol.29
, pp. 1034-40
-
-
Costa, S.L.1
Proctor, L.2
Dodd, J.M.3
Toal, M.4
Okun, N.5
Johnson, J.A.6
-
47
-
-
70349338116
-
First-Trimester prediction of hypertensive disorders in pregnancy
-
Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-Trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-8.
-
(2009)
Hypertension
, vol.53
, pp. 812-8
-
-
Poon, L.C.1
Kametas, N.A.2
Maiz, N.3
Akolekar, R.4
Nicolaides, K.H.5
-
48
-
-
33847618756
-
Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia
-
e1-6
-
Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 2007;196:239 e1-6.
-
(2007)
Am J Obstet Gynecol
, vol.196
, pp. 239
-
-
Vatten, L.J.1
Eskild, A.2
Nilsen, T.I.3
Jeansson, S.4
Jenum, P.A.5
Staff, A.C.6
-
49
-
-
70350320956
-
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-Angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
-
Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-Angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009; 22:1021-38.
-
(2009)
J Matern Fetal Neonatal Med
, vol.22
, pp. 1021-38
-
-
Kusanovic, J.P.1
Romero, R.2
Chaiworapongsa, T.3
Erez, O.4
Mittal, P.5
Vaisbuch, E.6
-
50
-
-
34548446787
-
Angiogenic factors for the prediction of preeclampsia in high-risk women
-
e1-8
-
Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007;197:244 e1-8.
-
(2007)
Am J Obstet Gynecol
, vol.197
, pp. 244
-
-
Moore Simas, T.A.1
Crawford, S.L.2
Solitro, M.J.3
Frost, S.C.4
Meyer, B.A.5
Maynard, S.E.6
-
51
-
-
84857634410
-
Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy
-
Perni U, Sison C, Sharma V, Helseth G, Hawfield A, Suthanthiran M, August P. Angiogenic factors in superimposed preeclampsia: A longitudinal study of women with chronic hypertension during pregnancy. Hypertension 2012;59:740-6.
-
(2012)
Hypertension
, vol.59
, pp. 740-6
-
-
Perni, U.1
Sison, C.2
Sharma, V.3
Helseth, G.4
Hawfield, A.5
Suthanthiran, M.6
August, P.7
-
52
-
-
78149431733
-
Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies
-
Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, et al. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 2010;5:e13263.
-
(2010)
PLoS One
, vol.5
-
-
Powers, R.W.1
Jeyabalan, A.2
Clifton, R.G.3
Van Dorsten, P.4
Hauth, J.C.5
Klebanoff, M.A.6
-
53
-
-
50349089750
-
Serum inhibin a and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension are they useful markers for prediction of subsequent preeclampsia?
-
e1-9
-
Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, et al. Serum inhibin a and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: Are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 2008;199:268 e1-9.
-
(2008)
Am J Obstet Gynecol
, vol.199
, pp. 268
-
-
Sibai, B.M.1
Koch, M.A.2
Freire, S.3
Pintoe Silva, J.L.4
Rudge, M.V.5
Martins-Costa, S.6
-
54
-
-
49949114898
-
Predictive value of angiogenic factors and uterine artery doppler for earlyversus late-onset pre-eclampsia and intrauterine growth restriction
-
Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery doppler for earlyversus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:303-9.
-
(2008)
Ultrasound Obstet Gynecol
, vol.31
, pp. 303-9
-
-
Crispi, F.1
Llurba, E.2
Dominguez, C.3
Martin-Gallan, P.4
Cabero, L.5
Gratacos, E.6
-
55
-
-
46749094190
-
Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery doppler velocimetry
-
Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE. Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery doppler velocimetry. Int J Gynaecol Obstet 2008;102:146-51.
-
(2008)
Int J Gynaecol Obstet
, vol.102
, pp. 146-51
-
-
Diab, A.E.1
El-Behery, M.M.2
Ebrahiem, M.A.3
Shehata, A.E.4
-
56
-
-
33947679731
-
Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery doppler velocimetry and placental growth factor
-
Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007;196:326 e1-13.
-
(2007)
Am J Obstet Gynecol
, vol.196
-
-
Espinoza, J.1
Romero, R.2
Nien, J.K.3
Gomez, R.4
Kusanovic, J.P.5
Goncalves, L.F.6
-
57
-
-
38349087878
-
Circulatory soluble endoglin and its predictive value for preeclampsia in secondtrimester pregnancies with abnormal uterine perfusion
-
Stepan H, Geipel A, Schwarz F, Kramer T, Wessel N, Faber R. Circulatory soluble endoglin and its predictive value for preeclampsia in secondtrimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 2008;198:175 e1-6.
-
(2008)
Am J Obstet Gynecol
, vol.198
-
-
Stepan, H.1
Geipel, A.2
Schwarz, F.3
Kramer, T.4
Wessel, N.5
Faber, R.6
-
58
-
-
34047232484
-
Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion
-
DOI 10.1161/01.HYP.0000258404.21552.a3
-
Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007;49:818-24. (Pubitemid 351664216)
-
(2007)
Hypertension
, vol.49
, Issue.4
, pp. 818-824
-
-
Stepan, H.1
Unversucht, A.2
Wessel, N.3
Faber, R.4
-
59
-
-
34347249118
-
Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
-
Salahuddin S, Lee Y, Vadnais M, Sachs BP, Karumanchi SA, Lim KH. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynecol 2007;197:28 e1-6.
-
(2007)
Am J Obstet Gynecol
, vol.197
-
-
Salahuddin, S.1
Lee, Y.2
Vadnais, M.3
Sachs, B.P.4
Karumanchi, S.A.5
Lim, K.H.6
-
60
-
-
3442884269
-
Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award
-
Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Goncalves LF, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 2004;190:1541-7.
-
(2004)
Am J Obstet Gynecol
, vol.190
, pp. 1541-7
-
-
Chaiworapongsa, T.1
Romero, R.2
Espinoza, J.3
Bujold, E.4
Mee Kim, Y.5
Goncalves, L.F.6
-
61
-
-
80053958768
-
Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia
-
Veas CJ, Aguilera VC, Munoz IJ, Gallardo VI, Miguel PL, Gonzalez MA, et al. Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia. J Matern Fetal Neonatal Med 2011;24:1371-7.
-
(2011)
J Matern Fetal Neonatal Med
, vol.24
, pp. 1371-7
-
-
Veas, C.J.1
Aguilera, V.C.2
Munoz, I.J.3
Gallardo, V.I.4
Miguel, P.L.5
Gonzalez, M.A.6
-
62
-
-
34249908643
-
Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia
-
DOI 10.1097/01.AOG.0000264552.85436.a1, PII 0000625020070600000016
-
Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble fms-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007;109:1368-74. (Pubitemid 46869876)
-
(2007)
Obstetrics and Gynecology
, vol.109
, Issue.6
, pp. 1368-1374
-
-
Wikstrom, A.-K.1
Larsson, A.2
Eriksson, U.J.3
Nash, P.4
Norden-Lindeberg, S.5
Olovsson, M.6
-
63
-
-
14644443578
-
Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia
-
DOI 10.1016/j.ajog.2004.12.052
-
Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005;192:734-41. (Pubitemid 40311263)
-
(2005)
American Journal of Obstetrics and Gynecology
, vol.192
, Issue.3
, pp. 734-741
-
-
Buhimschi, C.S.1
Norwitz, E.R.2
Funai, E.3
Richman, S.4
Guller, S.5
Lockwood, C.J.6
Buhimschi, I.A.7
-
64
-
-
59849123575
-
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study
-
Herse F, Verlohren S, Wenzel K, Pape J, Muller DN, Modrow S, et al. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009;53:393-8.
-
(2009)
Hypertension
, vol.53
, pp. 393-8
-
-
Herse, F.1
Verlohren, S.2
Wenzel, K.3
Pape, J.4
Muller, D.N.5
Modrow, S.6
-
65
-
-
66849106737
-
The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia
-
Kim YN, Lee DS, Jeong DH, Sung MS, Kim KT. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn 2009;29:464-70.
-
(2009)
Prenat Diagn
, vol.29
, pp. 464-70
-
-
Kim, Y.N.1
Lee, D.S.2
Jeong, D.H.3
Sung, M.S.4
Kim, K.T.5
-
66
-
-
74549205785
-
Different profiles of circulating angiogenic factors and adipocytokines between early-And late-onset preeclampsia
-
Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y. Different profiles of circulating angiogenic factors and adipocytokines between early-And late-onset preeclampsia. BJOG 117:314-20.
-
BJOG
, vol.117
, pp. 314-20
-
-
Masuyama, H.1
Segawa, T.2
Sumida, Y.3
Masumoto, A.4
Inoue, S.5
Akahori, Y.6
Hiramatsu, Y.7
-
67
-
-
55149097472
-
Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by preeclampsia
-
Tripathi R, Rath G, Jain A, Salhan S. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by preeclampsia. Ann Anat 2008;190:477-89.
-
(2008)
Ann Anat
, vol.190
, pp. 477-89
-
-
Tripathi, R.1
Rath, G.2
Jain, A.3
Salhan, S.4
-
68
-
-
34047196414
-
Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia
-
DOI 10.1291/hypres.30.151
-
Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Arai F, et al. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007;30:151-9. (Pubitemid 46541789)
-
(2007)
Hypertension Research
, vol.30
, Issue.2
, pp. 151-159
-
-
Ohkuchi, A.1
Hirashima, C.2
Matsubara, S.3
Suzuki, H.4
Takahashi, K.5
Arai, F.6
Watanabe, T.7
Kario, K.8
Suzuki, M.9
-
69
-
-
80255122679
-
Angiogenic factors as diagnostic tests for preeclampsia: A performance comparison between two commercial immunoassays
-
Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, von Dadelszen P. Angiogenic factors as diagnostic tests for preeclampsia: A performance comparison between two commercial immunoassays. Am J Obstet Gynecol 2011;205:469.e1-8.
-
(2011)
Am J Obstet Gynecol
, vol.205
-
-
Benton, S.J.1
Hu, Y.2
Xie, F.3
Kupfer, K.4
Lee, S.W.5
Magee, L.A.6
Von Dadelszen, P.7
-
70
-
-
77951945121
-
Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia
-
Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S, Suzuki M. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res 2010; 33:422-7.
-
(2010)
Hypertens Res
, vol.33
, pp. 422-7
-
-
Ohkuchi, A.1
Hirashima, C.2
Suzuki, H.3
Takahashi, K.4
Yoshida, M.5
Matsubara, S.6
Suzuki, M.7
-
71
-
-
77952953001
-
Multicenter evaluation of the first automated elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia
-
Schiettecatte J, Russcher H, Anckaert E, Mees M, Leeser B, Tirelli AS, et al. Multicenter evaluation of the first automated elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin Biochem 2010;43:768-70.
-
(2010)
Clin Biochem
, vol.43
, pp. 768-70
-
-
Schiettecatte, J.1
Russcher, H.2
Anckaert, E.3
Mees, M.4
Leeser, B.5
Tirelli, A.S.6
-
72
-
-
72149103278
-
Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: A prospective clinical study
-
Sunderji S, Gaziano E, Wothe D, Rogers LC, Sibai B, Karumanchi SA, Hodges-Savola C. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: A prospective clinical study. Am J Obstet Gynecol 2010;202:40 e1-7.
-
(2010)
Am J Obstet Gynecol
, vol.202
-
-
Sunderji, S.1
Gaziano, E.2
Wothe, D.3
Rogers, L.C.4
Sibai, B.5
Karumanchi, S.A.6
Hodges-Savola, C.7
-
73
-
-
79952949639
-
Measurement of sVEGF R1 and PlGF in serum: Comparing prototype assays from Beckman Coulter, Inc. to R&D systems microplate assays
-
Wothe D, Gaziano E, Sunderji S, Romero R, Kusanovic JP, Rogers L, et al. Measurement of sVEGF R1 and PlGF in serum: Comparing prototype assays from Beckman Coulter, Inc. to R&D systems microplate assays. Hypertens Pregnancy 2011;30:18-27.
-
(2011)
Hypertens Pregnancy
, vol.30
, pp. 18-27
-
-
Wothe, D.1
Gaziano, E.2
Sunderji, S.3
Romero, R.4
Kusanovic, J.P.5
Rogers, L.6
-
74
-
-
80555143068
-
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia
-
Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci 2012;122:43-52.
-
(2012)
Clin Sci
, vol.122
, pp. 43-52
-
-
Verlohren, S.1
Stepan, H.2
Dechend, R.3
-
75
-
-
0035340134
-
Perinatal regionalization and neonatal mortality in North Carolina, 1968-1994
-
DOI 10.1067/mob.2001.114484
-
Bode MM, O'Shea T M, Metzguer KR, Stiles AD. Perinatal regionalization and neonatal mortality in North Carolina, 1968-1994. Am J Obstet Gynecol 2001;184:1302-7. (Pubitemid 32434291)
-
(2001)
American Journal of Obstetrics and Gynecology
, vol.184
, Issue.6
, pp. 1302-1307
-
-
Bode, M.M.1
O'Shea, T.M.2
Metzguer, K.R.3
Stiles, A.D.4
-
76
-
-
0036246353
-
Mortality in low birth weight infants according to level of neonatal care at hospital of birth
-
DOI 10.1542/peds.109.5.745
-
Cifuentes J, Bronstein J, Phibbs CS, Phibbs RH, Schmitt SK, Carlo WA. Mortality in low birth weight infants according to level of neonatal care at hospital of birth. Pediatrics 2002;109:745-51. (Pubitemid 34493337)
-
(2002)
Pediatrics
, vol.109
, Issue.5
, pp. 745-751
-
-
Cifuentes, J.1
Bronstein, J.2
Phibbs, C.S.3
Phibbs, R.H.4
Schmitt, S.K.5
Carlo, W.A.6
-
77
-
-
0034526762
-
Association between level of delivery hospital and neonatal outcomes among South Carolina medicaid recipients
-
DOI 10.1067/mob.2000.107357
-
Sanderson M, Sappenfield WM, Jespersen KM, Liu Q, Baker SL. Association between level of delivery hospital and neonatal outcomes among South Carolina Medicaid recipients. Am J Obstet Gynecol 2000;183:1504-11. (Pubitemid 32061216)
-
(2000)
American Journal of Obstetrics and Gynecology
, vol.183
, Issue.6
, pp. 1504-1511
-
-
Sanderson, M.1
Sappenfield, W.M.2
Jespersen, K.M.3
Liu, Q.4
Baker, S.L.5
-
78
-
-
34249001303
-
Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data
-
DOI 10.1016/S0140-6736(07)60712-0, PII S0140673607607120
-
Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of preeclampsia: A meta-Analysis of individual patient data. Lancet 2007;369:1791-8. (Pubitemid 46782996)
-
(2007)
Lancet
, vol.369
, Issue.9575
, pp. 1791-1798
-
-
Askie, L.M.1
Duley, L.2
Henderson-Smart, D.J.3
Stewart, L.A.4
-
79
-
-
80052149662
-
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia
-
Thadhani R, Kisner T, Hagmann H, Bossung V, Noack S, Schaarschmidt W, et al. Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 2011; 124:940-50.
-
(2011)
Circulation
, vol.124
, pp. 940-50
-
-
Thadhani, R.1
Kisner, T.2
Hagmann, H.3
Bossung, V.4
Noack, S.5
Schaarschmidt, W.6
-
80
-
-
34247247725
-
Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1
-
DOI 10.1161/CIRCULATIONAHA.106.660134, PII 0000301720070403000015
-
Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007;115: 1789-97. (Pubitemid 46648616)
-
(2007)
Circulation
, vol.115
, Issue.13
, pp. 1789-1797
-
-
Cudmore, M.1
Ahmad, S.2
Al-Ani, B.3
Fujisawa, T.4
Coxall, H.5
Chudasama, K.6
Devey, L.R.7
Wigmore, S.J.8
Abbas, A.9
Hewett, P.W.10
Ahmed, A.11
-
81
-
-
78650950716
-
Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: First experience]
-
[German]
-
Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J. [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: First experience]. Z Geburtshilfe Neonatol 2010;214:234-8. [German]
-
(2010)
Z Geburtshilfe Neonatol
, vol.214
, pp. 234-8
-
-
Stepan, H.1
Schaarschmidt, W.2
Jank, A.3
Verlohren, S.4
Kratzsch, J.5
-
82
-
-
84455208308
-
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
-
Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012;206:58 e1-8.
-
(2012)
Am J Obstet Gynecol
, vol.206
-
-
Verlohren, S.1
Herraiz, I.2
Lapaire, O.3
Schlembach, D.4
Moertl, M.5
Zeisler, H.6
-
83
-
-
80052974205
-
Maternal plasma concentrations of angiogenic/antiangiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia
-
Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E, et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 2011;24:1187-207.
-
(2011)
J Matern Fetal Neonatal Med
, vol.24
, pp. 1187-207
-
-
Chaiworapongsa, T.1
Romero, R.2
Savasan, Z.A.3
Kusanovic, J.P.4
Ogge, G.5
Soto, E.6
-
84
-
-
84857594613
-
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
-
Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012:125: 911-9.
-
(2012)
Circulation
, vol.125
, pp. 911-9
-
-
Rana, S.1
Powe, C.E.2
Salahuddin, S.3
Verlohren, S.4
Perschel, F.H.5
Levine, R.J.6
|